Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Instruments & Supplies

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.

Revenue projections:

Revenue projections for SOLV
Revenue projections for SOLV

With SOLV's revenue forecasted to drop below last year's level, investors are expected to take a cautious stance. Such declines typically affect a company's bottom line, reducing profitability and making investors hesitant to invest heavily in the company until financial performance improves.

Financial Ratios:

currentRatio 1.021000
forwardPE 12.110477
debtToEquity 110.313000
earningsGrowth 0.039000
revenueGrowth 0.022000
grossMargins 0.547770
operatingMargins 0.097780
trailingEps 8.180000
forwardEps 7.221020

SOLV's current ratio is 1.021, signaling that the company has sufficient cash reserves and current assets to cover its short-term debt obligations. This suggests financial stability, as SOLV should not face any issues meeting its short-term liabilities with available resources.
Solventum Corporation's Forward PE ratio is in a good range, reflecting a reasonable balance between stock price and earnings. The stock is not overpriced, leaving room for growth, which suggests potential for investors looking to capitalize on future value appreciation.
SOLV's high debt-to-equity ratio indicates a strong reliance on debt, meaning the company is heavily leveraged. This could increase financial risks if cash flow or earnings decline, making it more difficult for SOLV to manage its debt obligations.
SOLV's negative gross and operating margins highlight potential financial struggles, as the company is not covering its production or operational expenses. This could lead to broader concerns about its ability to achieve profitability.
Solventum Corporation's forward EPS being lower than its trailing EPS suggests the company is expected to see reduced profitability in the current financial year compared to the previous one. This signals a potential decline in earnings, raising concerns about future financial performance.

Price projections:

Price projections for SOLV
Price projections for SOLV

The price of Solventum Corporation has remained consistently close to the lower limit of projections. This ongoing pattern raises concerns about the stock's performance and may reflect market hesitance regarding the company's growth prospects.

Insider Transactions:

Insider Transactions for SOLV
Insider Transactions for SOLV


SOLV saw 1 transactions in which shares were sold with market price at 71.41999816894531.1 transactions to buy SOLV shares were recorded, with market price at 67.5999984741211.The insider transaction data shows no clear pattern or trend, making it difficult to draw any meaningful conclusions about the company's current direction based on this information.

Recommendation changes over time:

Recommendations trend for SOLV
Recommendations trend for SOLV


SOLV has been receiving a buy bias from analysts, indicating confidence in its investment potential. This could drive more investors to view SOLV as a reliable choice for their money, offering a promising avenue for future growth and financial gains.